Detection of Mycobacterium tuberculosis DNA in Respiratory Aerosols Using Electrostatic Sampling

Overview

This study demonstrates the feasibility of detecting Mycobacterium tuberculosis (Mtb) DNA in respiratory aerosols collected from symptomatic adults in primary care settings using a novel electrostatic sampler. The aerosol detection showed moderate sensitivity and specificity compared to sputum testing and identified clinical factors associated with aerosol Mtb DNA presence.

Background

Tuberculosis (TB) remains a major global health challenge with significant detection gaps, particularly due to difficulties in obtaining sputum samples from some patients. Aerosolized Mtb detection offers a promising non-sputum-based diagnostic approach that may better predict infectiousness and transmission risk. Existing aerosol sampling methods are complex and limited to research settings, highlighting the need for practical tools applicable in primary care. This study evaluates the TB Hotspot Detector, a portable electrostatic aerosol sampler, for detecting Mtb DNA in cough aerosols of symptomatic adults in South Africa.

Data Highlights

Key Findings

• Aerosol Mtb DNA detection sensitivity was 46.6% and specificity was 76.5% compared to sputum Ultra testing.
• Sensitivity increased to 56.9% in participants with high sputum Ultra semiquantitative results.
• Male sex combined with medium or higher sputum Ultra results was associated with a 3.26-fold increased risk of aerosol Mtb DNA detection.
• Reported fever was inversely associated with aerosol Mtb DNA detection, though not statistically significant.
• Some participants exhibited high sputum to aerosol ratios (≥0.75), indicating strong capacity to expel Mtb DNA via aerosols.
• Despite rigorous decontamination, 30% of environmental samples tested positive for aerosol Mtb DNA, suggesting potential nosocomial transmission risks.

Clinical Implications

Electrostatic aerosol sampling using the TB Hotspot Detector is a feasible method for detecting infectious tuberculosis in primary care settings and may complement sputum-based diagnostics. This approach could help identify highly infectious individuals and inform targeted interventions to reduce TB transmission. However, environmental contamination risks underscore the need for strict infection control measures during aerosol sampling.

Conclusion

The study supports the use of portable electrostatic aerosol samplers for detecting Mtb DNA in respiratory aerosols in primary care, providing a promising tool to enhance TB diagnosis and transmission risk assessment. Further research is warranted to optimize this technology and evaluate its role in diverse patient populations.

References

1. World Health Organization 2023 -- Global Tuberculosis Report
2. End TB Strategy 2015 -- WHO Targets for TB Reduction
3. TB Hotspot Detector Study 2024 -- Detection of Mycobacterium tuberculosis DNA in Respiratory Aerosols